In Q2 announcement, we should hear more about potentially larger market opportunity for vitiligo due to the recent INCY approval:
An Article from TheStreet, page-2
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.01 |
Change
-0.010(0.33%) |
Mkt cap ! $212.1M | |||
| Open | High | Low | Value | Volume |
| $3.03 | $3.03 | $2.97 | $144.1K | 48.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1409 | $2.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.00 | 10000 | 1 |
View Market Depth
| Last trade - 15.56pm 10/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |